| Financial Year |
March 31 2023 |
| Monetary Funds |
144,334,957.53 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
314,923,955.77 |
| Advances to Suppliers |
52,275,345.74 |
| Other Receivables |
47,246,517.09 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
656,504,788.04 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
48,796,251.45 |
| Total Current Assets |
1,685,879,029.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
2,396,397,262.23 |
| Under-construction Projects |
1,074,471,165.18 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
142,203,473.08 |
| R&D expenses |
-- |
| Goodwill |
131,744,551.75 |
| Long-Term Deferred and Prepaid Expenses |
3,611,033.28 |
| Deferred Income Tax Assets |
20,133,662.03 |
| Other Non-Current Assets |
176,680,089.33 |
| Sub-Total of Non-Current Assets |
3,969,734,333.45 |
| Total Assets |
5,655,613,362.62 |
| Short-Term Loans |
471,801,979.57 |
| Trading Financial liabilities |
-- |
| Notes Payable |
146,270,000.00 |
| Accounts Payable |
550,110,070.31 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
34,528,903.49 |
| Taxes Payable |
34,792,084.32 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
151,214,798.27 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
92,592,458.51 |
| Other Current Liabilities |
332,437,637.70 |
| Sub-Total of Current Liabilities |
1,880,084,797.40 |
| Long-term Loans |
559,450,000.00 |
| Bonds Payable |
615,533,743.23 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
691,370.49 |
| Deferred Income Tax Liabilities |
43,575,993.82 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,232,227,472.60 |
| Total Liabilities |
3,112,312,270.00 |
| Paid-In Capital(Or Share Stock) |
270,802,337.00 |
| Capital Surplus |
829,847,173.75 |
| Surplus Reserve |
60,793,858.21 |
| LESS:Treasury Stock |
57,941,399.25 |
| Undistributed Profits |
1,180,550,531.02 |
| Minority Stockholder's Interest |
1,124,877.11 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,542,176,215.51 |
| Owner's Equity（Stockholder's Equity） |
2,543,301,092.62 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,655,613,362.62 |
